Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Giosafat Spitaleri1, MD; Elisabetta Moscarella1, MD; Salvatore Brugaletta1*, MD, PhD; Alberto Pernigotti1, MD; Luis Ortega-Paz1, MD; Josep Gomez-Lara2, MD, PhD; Angel Cequier2, MD; Andrés Iñiguez3, MD; Antonio Serra4, MD; Pilar Jiménez-Quevedo5, MD; Vicente Mainar6, MD; Gianluca Campo7, MD; Maurizio Tespili8, MD; Peter den Heijer9, MD; Armando Bethencourt10, MD; Nicolás Vazquez11, MD; Marco Valgimigli12, MD, PhD; Patrick W. Serruys13, MD, PhD; Manel Sabaté